Last reviewed · How we verify

NCT03148392

Assess Differences in Pain Following Cryo and Radiofrequency Atrial Fibrillation Ablation

Status unknown Last updated 28 August 2019
What this trial tests

trial in Atrial Fibrillation in 100 participants. Status unknown.

Timeline
16 May 2017
Primary endpoint
1 November 2019
31 December 2019

Quick facts

Lead sponsorSumit Verma, MD
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment100
Start date16 May 2017
Primary completion1 November 2019
Estimated completion31 December 2019
Sites1 location across United States

Conditions studied

Sponsor

Sumit Verma, MD

Who can join

Adults 18 to 80, any sex, with Atrial Fibrillation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary objective is to assess any differences in patient quality of life between Cryo Balloon ablation and Radiofrequency ablation in the treatment of atrial fibrillation. The study will also assess any differences in the amount and duration of pain medication required after the ablation.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Atrial Fibrillation

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03148392.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing